surmount-1 trial tirzepatide weight loss non-diabetic obesity Effect of in trial. (BMI: body mass index; CI: surmount-1 trial tirzepatide – Tirzepatide after intensive lifestyle intervention – SURMOUNT-1: Tirzepatide Drastically Reduces Weight

Weeks 8-12 : More significant improvements in deeper wrinkles, continued collagen density increase, improved skin thickness (measured via ultrasound in clinical settings), and sustained reduction in age-related skin laxity

A further study by Crimarco A [19] found that a 8 week plant based diet significantly reduced TMAO production, and further, that after switching the diet to include animal based protein, TMAO production was less than the participants who had only been given an animal protein based diet

Keep the GLP-1

Without the metabolic boost from GLP-1s, your energy expenditure may drop, making it easier to regain weight

Why does this distinction matter

Our nasal delivery products are developed with quality-focused standards to support studies involving absorption pathways, delivery mechanisms, and targeted research models